SCHEMBL24668656

SCHEMBL24668656

NS(=O)(=O)c1cc(CCCBr)co1

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CA2 P00918 11/20 0.38
PDPK1 O15530 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24668653 0.84 CA2 (0.50) CA2
SCHEMBL24670395 0.67 CA2 (0.42) CA2PDPK1
SCHEMBL21586454 0.65 CA2 (0.58) CA2
SCHEMBL12671956 0.63 TDP1 (0.35)
SCHEMBL24668657 0.63 LOX (0.34) CA2PDPK1SMN1; SMN2
SCHEMBL24669733 0.62 PDPK1 (0.31) PDPK1
SCHEMBL7139485 0.62 CA2 (0.42) CA2
SCHEMBL30067654 0.60 CA2 (0.54) CA2SMN1; SMN2
SCHEMBL24743674 0.60 CA2 (0.45) CA2
SCHEMBL14466905 0.60 PTGS2 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022187693-A1 COVALENT CDK2-BINDING COMPOUNDS FOR THERAPEUTIC PURPOSES UMBRA THERAPEUTICS INC. (US) 2022-09-09 WO disclosed